{"text": ["Why", "Akcea", "Therapeutics,", "Inc.", "Is", "Soaring", "While", "Ionis", "Pharmaceuticals", "Is", "Dropping"], "created_at": "2018-03-15 18:08:19"}
{"text": ["Why", "Akcea", "Therapeutics,", "Inc.", "Is", "Soaring", "While", "Ionis", "Pharmaceuticals", "Is", "Dropping"], "created_at": "2018-03-15 18:08:19"}
{"text": ["What", "Analysts", "Recommend", "for", "Novartis", "in", "March", "2018"], "created_at": "2018-03-15 14:31:01"}
{"text": ["How", "Pfizer", "Plans", "to", "Move", "Into", "the", "Big", "Leagues", "for", "Cancer", "Treatment"], "created_at": "2018-03-15 14:09:12"}
{"text": ["How", "Pfizer", "Plans", "to", "Move", "Into", "the", "Big", "Leagues", "for", "Cancer", "Treatment"], "created_at": "2018-03-15 14:09:12"}
{"text": ["Must-Know", "Recent", "Developments", "from", "Novartis"], "created_at": "2018-03-15 13:01:25"}
{"text": ["How", "Novartis\u2019s", "Alcon", "Performed", "in", "4Q17"], "created_at": "2018-03-15 11:32:05"}
{"text": ["Swiss", "Pharma", "Gets", "a", "Taste", "of", "Silicon", "Valley"], "created_at": "2018-03-15 05:00:00"}
